Sensus Healthcare announces the Sensus Cloud™; Unveils New Features at American Academy of Dermatology (AAD) Annual Meeting in New Orleans March 17-19
New comprehensive asset and EMR management feature allows users to collect real-time information from the device to manage and maintain multiple machines with Chat GPTBOCA RATON, FL, March 16, 2023 -- Sensus Healthcare, Inc.(Nasdaq:SRTS), the leading manufacturer of...
Sensus Healthcare Fourth Quarter 2022 Financial Results Include Quarterly Revenues of $13.1 Million
Full-year revenues increased 65% to $44.5 million Investments in technology and staff position Sensus for growth in 2023 and beyond Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 09, 2023 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a...
Sensus Healthcare to Host Fourth Quarter 2022 Financial Results and Business Update Conference Call on February 9, 2023
BOCA RATON, Fla., Feb. 01, 2023 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on...
Sensus Healthcare Announces Senior Management Appointments and Promotions
BOCA RATON, Fla, Jan. 09, 2023 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, is pleased to announce...
Sensus Healthcare Announces Preliminary Fourth Quarter 2022 Revenues
Fourth quarter revenues to exceed $13 million; full year revenues to exceed $44 million, representing growth of 60% BOCA RATON, Fla, Jan. 05, 2023 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive,...